Related Experiment Video
Updated: May 9, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Bax phosphorylation association with nucleus and oligomerization after neonatal hypoxia-ischemia
Smitha Krishna Infante1, Andres F Oberhauser, J Regino Perez-Polo
1Northern Kentucky University, Highland Heights, Kentucky, USA.
Insights
Neonatal hypoxia-ischemia (HI) brain injury is linked to increasing preterm births. Bax protein phosphorylation controls its movement and clumping, determining cell death type and guiding new therapeutic strategies.
Area of Science:
- Neuroscience
- Cell Biology
- Developmental Biology
Background:
- Neonatal hypoxia-ischemia (HI) is a significant cause of brain injury in preterm infants, with increasing incidence.
- Understanding the mechanisms of cell death following HI is crucial for developing targeted treatments.
- Neuroinflammation plays a key role in secondary apoptosis after severe HI.
Purpose of the Study:
- To characterize the biochemical pathways of cell death after neonatal HI.
- To investigate the role of Bax protein activation, translocation, and oligomerization in HI-induced brain injury.
- To determine if kinase-specific phosphorylation of Bax controls its intracellular localization and cell death phenotype.
Main Methods:
- Utilized established in vivo and in vitro models of neonatal HI.
- Characterized Bax oligomerization and multiorganelle translocation patterns.
- Investigated the impact of HI-dependent phosphorylation on Bax function.
Main Results:
- Bax protein is activated and translocates to the nucleus, endoplasmic reticulum, and mitochondria after HI.
- HI-dependent phosphorylation of Bax dictates its oligomerization status.
- Bax translocation and oligomerization patterns are critical in determining the necrotic or apoptotic cell death phenotype observed after HI.
Conclusions:
- Kinase-specific phosphorylation of Bax is a key regulator of its intracellular localization and oligomerization.
- Understanding Bax translocation mechanisms can inform the development of therapies to mitigate HI-associated brain injury and inflammation.
- Targeting Bax phosphorylation offers a potential therapeutic avenue for neonatal HI.
Abstract:
Neonatal hypoxia-ischemia (HI) is a common occurrence in preterm and low-birth-weight infants, and the incidence of low-birth-weight and preterm births is increasing. Characterization of brain injury after HI is of critical importance in developing new treatments that more accurately target the injury. After severe HI, neuronal cells undergo necrosis and secondary apoptosis of the surrounding cells as a result of neuroinflammation. We sought to characterize the biochemical pathways associated with cell death after HI. Bax, a cell death signaling protein, is activated after HI and translocates to the nucleus, endoplasmic reticulum, and mitochondria. The translocation patterns of Bax affect the resultant cell death phenotype (necrotic or apoptotic) observed. Although Bax is known to oligomerize once it is activated, less is known about the factors that control its translocation and oligomerization. We hypothesize that Bax kinase-specific phosphorylation determines its oligomerization and intracellular localization. Using well-established in vivo and in vitro models of neonatal HI, we characterized Bax oligomerization and multiorganelle translocation. We found that HI-dependent phosphorylation of Bax determines its oligomerization status and multiorganelle localization, and, ultimately, the cell death phenotype observed. Understanding the mechanisms of Bax translocation will aid in the rational design of therapeutic strategies that decrease the trauma resulting from HI-associated inflammation.
Related Concept Videos
The Intrinsic Apoptotic Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Nuclear Protein Sorting
Cellular Injury V: Apoptosis and Autophagy
The JAK-STAT Signaling Pathway
Regulation of Angiogenesis and Blood Supply
